Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Cytomics was a biotechnology company that specialized in the development of high-content analysis tools for single-cell research. The company's core technology, the Optical LiveCell Array (LCA), provided a platform for the real-time, multi-parametric study of individual living cells within a population. These tools were utilized in various applications, including drug discovery, oncology research, and clinical diagnostics, to monitor cellular processes like apoptosis and multidrug resistance. Molecular Cytomics established a significant partnership with Nalge Nunc (now part of Thermo Fisher Scientific) to market its products under the Nunc brand. The company was headquartered in Boston, Massachusetts, with research facilities in Israel, before ceasing operations in 2014.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Cytomics.